SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001274173-23-000080
Filing Date
2023-05-25
Accepted
2023-05-25 11:17:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 RULE 12D-1C - BELLEROPHON bellerophon051523.txt SC 13G 11146
  Complete submission text file 0001274173-23-000080.txt   12943
Mailing Address 201 BISHOPSGATE LONDON X0 EC2M 3AE
Business Address 201 BISHOPSGATE LONDON X0 EC2M 3AE 442078181818
JANUS HENDERSON GROUP PLC (Filed by) CIK: 0001274173 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Y9 | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice

Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Subject) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88741 | Film No.: 23957805
SIC: 2834 Pharmaceutical Preparations